Takeda Pharmaceutical
276 hedge funds and large institutions have $772M invested in Takeda Pharmaceutical in 2022 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 95 increasing their positions, 67 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.47% more ownership
Funds ownership: 3.6% → 4.07% (+0.47%)
3% less capital invested
Capital invested by funds: $799M → $772M (-$26.7M)
2% less funds holding
Funds holding: 282 → 276 (-6)
Holders
276
Holding in Top 10
2
Calls
$26.5M
Puts
$7.22M
Top Buyers
| 1 | +$36.2M | |
| 2 | +$21.7M | |
| 3 | +$15.3M | |
| 4 |
Goldman Sachs
New York
|
+$8.87M |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
+$8.18M |
Top Sellers
| 1 | -$7.46M | |
| 2 | -$4.37M | |
| 3 | -$3.4M | |
| 4 |
HT
HAP Trading
New York
|
-$3.4M |
| 5 |
Jane Street
New York
|
-$2.57M |